MFLens
Trailing returns lie. Rolling data doesn’t.Nippon India Pharma Fund
Sector/ThematicNippon India Mutual Fund
GOOD QUALITY61/100
Ranks #23 of 94 Sector/Thematic funds
Consistency Score
82.0%
3Y rolling
Sharpe Ratio
0.61
3Y
Alpha
6.87%
vs benchmark · 3Y
CAGR
17.12%
3Y annualised
Full analysis at mflens.in
3 November 2026
Past performance does not guarantee future returns. Data via MFLens rolling analysis.